United States Medicated Shampoo Market Size & Outlook, 2026-2034
United States Medicated Shampoo Market Insights
- Based on Deep Market Insights findings, the United States Medicated Shampoo Market reached USD 1067.4 Million in 2025 and is estimated to attain USD 1666.64 Million by 2034.
- From 2026 to 2034, the United States market is expected to grow at a steady CAGR of 5.07%.
- Within the Active category, Antifungal dominated in 2025 in terms of market size contribution.
- Over the forecast period, Anti-dandruff is forecasted to deliver the fastest growth, positioning it as the most lucrative Active segment.
Source: DMI Analysis Company Publications, Primary Interviews.
Other Key Findings
- In 2025, United States accounted for 22.37% of the global Medicated Shampoo Market size.
- By 2034, United States is expected to lead the global Medicated Shampoo Market in terms of market size.
- Within North America, United States is projected to dominate the regional Medicated Shampoo Market size by 2034.
- United States is identified as the fastest-growing market in North America, anticipated to reach USD 1665.85 Million by 2034.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2025 |
| Study Period | 2022-2034 |
| Historical Period | 2022-2024 |
| Forecast Period | 2026-2034 |
| Market Size In 2025 | USD 1067.4 Million |
| Market Size In 2034 | USD 1666.64 Million |
| Largest segment | Antifungal |
| Units | Revenue in USD Million |
| CAGR | 5.07% (2026-2034) |
| Segmnetation Covered | |
| Active |
|
| Distribution |
|
| End-user |
|
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
United States Medicated Shampoo Market Active 2026-2034 (USD Million)
| Active | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Antifungal | XX.x | XX.x | XX.x | 533.06 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Anti-dandruff | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Therapeutic | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.
United States Medicated Shampoo Market Distribution 2026-2034 (USD Million)
| Distribution | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OTC | XX.x | XX.x | XX.x | 592.73 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Prescription | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.
United States Medicated Shampoo Market End-user 2026-2034 (USD Million)
| End-user | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adult | XX.x | XX.x | XX.x | 622.83 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Pediatric | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.